Evaluation of anticonvulsant activities of bis(3-aryl-3-oxo-propyl)ethylamine hydrochlorides and 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinol hydrochlorides

被引:1
|
作者
Gul, Halise Inci [1 ]
Calis, Unsal
Ozturk, Zeynep
Tutar, Emre
Calikiran, Leyla
机构
[1] Ataturk Univ, Fac Pharm, Dept Pharmaceut Chem, TR-25240 Erzurum, Turkey
[2] Univ Hacettepe, Fac Pharm, Dept Pharmaceut Chem, TR-06100 Ankara, Turkey
[3] Ataturk Univ, Fac Pharm, Erzurum, Turkey
来源
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2007年 / 57卷 / 03期
关键词
antiepileptics; Mannich bases; piperidinols; anticonvulsant activity; synthesis;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bis-Mannich bases, bis(3-aryl-3-oxopropyl)ethylamine hydrochlorides 1-4, and their corresponding structural and non-classical isomers, 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinol hydrochlorides 5-8, were synthesized. The aryl part was phenyl in 1 and 5, p-methylphenyl in 2 and 6, p-chlorophenyl in 3 and 7, and 2-thienyl in 4 and 8. The chemical stuructures of the compounds were confirmed by IH-NMR, C-13-NMR, UV, IR and elemental analyses. Anticonvulsant activities of the compounds were evaluated by the maximum electroshock (MES) and subcutaneous pentylenetetrazole (scMet) tests in the dose range of 30-300 mg/kg. Alterations in biological activity depending on modifications in chemical structure were also followed. Compounds 1-4,6, and 8 were toxic and caused death of the animals 20 min after the injection. Compounds 2,3 and 6 were also neurotoxic at the 100 mg/kg dose level. While only compound 7 was active in the scMet test at 300 mg/kg within 4 It, all the compounds showed activity in the MES test at different dose levels and time periods. In conclusion, compounds 5 and 7, which were not toxic and did not show neurotoxicity, seemed to be candidate compounds to develop new anticonvulsant compounds useful in the treatment of the grand mal (compounds 5,7) and petit mal (compound 7) epilepsies.
引用
收藏
页码:133 / 136
页数:4
相关论文
共 50 条
  • [31] The synthesis and antibacterial activities of 2,5-bis[(3-aryl)-1,2,4-triazolo[3,4-b]-[1,3,4] thiadiazole-6-yl]thiophenes
    Li, Dejiang
    Fu, Heqing
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2008, 183 (09) : 2229 - 2236
  • [32] Synthesis and anticancer activities of 1,4-bis(6-aryl-1,2,4-triazolo[3,4-b]-[1,3,4]thiadiazole-3-yl)benzene derivatives
    Ding, Hao-Yu
    Li, De-Jiang
    HETEROCYCLIC COMMUNICATIONS, 2011, 17 (1-2) : 69 - 71
  • [33] Synthesis and biological activities of 3-(2-furyl)-4-aryl-1, 2, 4-triazole-5-thiones
    Li, XZ
    Si, ZX
    CHINESE CHEMICAL LETTERS, 2002, 13 (02) : 129 - 132
  • [35] Synthesis and biological activities of 2-(1-aryl-3-methyl-5-chloro1H-pyrazol-4-yl)-3-(1-aroylamino)-4-thiazolidinones
    Wen, LP
    Li, M
    Jing, SX
    Cao, W
    Yang, HZ
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2005, 25 (02) : 197 - 200
  • [36] Synthesis of 4-aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate in ionic liquid
    Du, Bai-Xiang
    Li, Yu-Ling
    Wang, Xiang-Shan
    Zhang, Mei-Mei
    Shi, Da-Qing
    Tu, Shu-Jiang
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2006, 26 (05) : 698 - 701
  • [37] 3-ACETYL-4-ARYL-5-OXO-2,7,7-TRIMETHYL-1,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AND THEIR CALCIUM ANTAGONISTIC ACTIVITIES
    SAFAK, C
    OZKANLI, F
    EROL, K
    AKTAN, Y
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-2 (11): : 1154 - 1156
  • [38] Synthesis of 1,4-bis[(3-Aryl)-s-triazolo (3,4-b)-(1,3,4)thiadiazole-6-yl]benzenes
    Li, DJ
    Long, DQ
    Fu, HQ
    SYNTHETIC COMMUNICATIONS, 2005, 35 (19) : 2495 - 2500
  • [39] Synthesis and electrochemical properties of 2,6-bis(6-aryl-[1,2,4]-triazolo[3,4-b][1,3,4]-thiadiazole-3-yl)pyridines
    Tan, Chun Xia
    Feng, Ruo Fei
    Peng, Xiao Xia
    CHINESE CHEMICAL LETTERS, 2007, 18 (05) : 505 - 508
  • [40] Synthesis, 5-Hydroxytryptamine1A Receptor Affinity and Docking Studies of 3-[3-(4-Aryl-1-piperazinyl)-propyl]-1H-Indole Derivatives
    Pessoa-Mahana, Hernan
    Ugarte Nunez, Catalina
    Araya-Maturana, Ramiro
    Saitz Barria, Claudio
    Zapata-Torres, Gerald
    David Pessoa-Mahana, Carlos
    Iturriaga-Vasquez, Patricio
    Mella-Raipan, Jaime
    Reyes-Parada, Miguel
    Celis-Barros, Cristian
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2012, 60 (05) : 632 - 638